How Doctors Are Fighting Multiple Myeloma in Adults Over 40

Health Points

• Multiple myeloma is a blood cancer that weakens bones and lowers immunity
• Treatment usually combines targeted drugs, stem cell transplant, and ongoing monitoring
• Early diagnosis and consistent follow-up improve long-term outcomes for patients over 40

Multiple myeloma starts in the bone marrow where abnormal plasma cells crowd out healthy blood cells. This can lead to fatigue, bone pain, and frequent infections.

Doctors begin with a detailed exam and blood tests to confirm the diagnosis. Imaging and bone marrow biopsies help determine the stage and guide therapy choices.

Most patients receive a combination of medicines that target cancer cells while sparing healthy tissue. A stem cell transplant may follow if the patient is healthy enough to tolerate it.

“We tailor treatment to each person’s age and overall health,” says Dr. Lisa Rivera, a hematologist at Memorial Regional Cancer Center.

After initial therapy, regular check-ups track the disease and adjust medications as needed. Supportive care for bone strength and infection prevention is also part of the plan.

“Staying active and eating well can make a real difference in how patients feel during treatment,” adds nutritionist Mark Ellison.

Clinical trials continue to test new drugs and combinations, offering hope for longer remission. Patients are encouraged to discuss these options with their care teams.